Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Jun 5;35(25):3295-3302. doi: 10.1016/j.vaccine.2017.04.037. Epub 2017 Apr 22. Review.

2.

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Jun 5;35(25):3303-3308. doi: 10.1016/j.vaccine.2017.04.035. Epub 2017 Apr 23. Review.

3.

Public Health Surveillance: A Tool for Targeting and Monitoring Interventions.

Nsubuga P, White ME, Thacker SB, Anderson MA, Blount SB, Broome CV, Chiller TM, Espitia V, Imtiaz R, Sosin D, Stroup DF, Tauxe RV, Vijayaraghavan M, Trostle M.

In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editors. Disease Control Priorities in Developing Countries. 2nd edition. Washington (DC): World Bank; 2006. Chapter 53.

4.

Federal role in early detection preparedness systems.

Broome CV.

MMWR Suppl. 2005 Aug 26;54:7-9.

PMID:
16177686
6.

Statutory basis for public health reporting beyond specific diseases.

Broome CV, Horton HH, Tress D, Lucido SJ, Koo D.

J Urban Health. 2003 Jun;80(2 Suppl 1):i14-22.

7.

On the threshold.

Broome CV, Pinner RW, Sosin DM, Treadwell TA.

Am J Prev Med. 2002 Oct;23(3):229-30. No abstract available.

PMID:
12350458
8.
9.

A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations.

Mulholland K, Smith PG, Broome CV, Gaye A, Whittle H, Greenwood BM.

Int J Tuberc Lung Dis. 1999 Sep;3(9):749-55. Review.

PMID:
10488880
10.

Effective global response to emerging infectious diseases.

Broome CV.

Emerg Infect Dis. 1998 Jul-Sep;4(3):358-9. No abstract available.

11.

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.

Perkins BA, Jonsdottir K, Briem H, Griffiths E, Plikaytis BD, Hoiby EA, Rosenqvist E, Holst J, Nokleby H, Sotolongo F, Sierra G, Campa HC, Carlone GM, Williams D, Dykes J, Kapczynski D, Tikhomirov E, Wenger JD, Broome CV.

J Infect Dis. 1998 Mar;177(3):683-91.

PMID:
9498448
12.

Meningococcal vaccine in sub-Saharan Africa.

Perkins BA, Broome CV, Rosenstein NE, Schuchat A, Reingold AL.

Lancet. 1997 Dec 6;350(9092):1708; author reply 1709-10. No abstract available.

PMID:
9400540
13.

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

Leach A, Twumasi PA, Kumah S, Banya WS, Jaffar S, Forrest BD, Granoff DM, LiButti DE, Carlone GM, Pais LB, Broome CV, Greenwood BM.

J Infect Dis. 1997 Jan;175(1):200-4.

PMID:
8985221
14.

Epidemiology and prevention of meningococcal disease.

Riedo FX, Plikaytis BD, Broome CV.

Pediatr Infect Dis J. 1995 Aug;14(8):643-57. Review. No abstract available.

PMID:
8532420
15.

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Twumasi PA Jr, Kumah S, Leach A, O'Dempsey TJ, Ceesay SJ, Todd J, Broome CV, Carlone GM, Pais LB, Holder PK, et al.

J Infect Dis. 1995 Mar;171(3):632-8.

PMID:
7876610
16.

Pneumococcal vaccine after 15 years of use. Another view.

Fedson DS, Shapiro ED, LaForce FM, Mufson MA, Musher DM, Spika JS, Breiman RF, Broome CV.

Arch Intern Med. 1994 Nov 28;154(22):2531-5. No abstract available.

PMID:
7979849
17.

Cerebrospinal meningitis epidemics.

Moore PS, Broome CV.

Sci Am. 1994 Nov;271(5):38-45. Review. No abstract available.

PMID:
7997865
18.

A point-source foodborne listeriosis outbreak: documented incubation period and possible mild illness.

Riedo FX, Pinner RW, Tosca ML, Cartter ML, Graves LM, Reeves MW, Weaver RE, Plikaytis BD, Broome CV.

J Infect Dis. 1994 Sep;170(3):693-6.

PMID:
8077731
19.

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.

Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR.

JAMA. 1993 Oct 20;270(15):1826-31.

PMID:
8411526
20.

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis.

Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith JD, Broome CV.

JAMA. 1993 Sep 22-29;270(12):1442-8.

PMID:
8371444
21.

Outbreak of early onset group B streptococcal sepsis.

Adams WG, Kinney JS, Schuchat A, Collier CL, Papasian CJ, Kilbride HW, Riedo FX, Broome CV.

Pediatr Infect Dis J. 1993 Jul;12(7):565-70.

PMID:
8345997
22.

Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD.

JAMA. 1993 Jan 13;269(2):221-6.

PMID:
8417239
23.

Public health policy for preventing violence.

Mercy JA, Rosenberg ML, Powell KE, Broome CV, Roper WL.

Health Aff (Millwood). 1993 Winter;12(4):7-29.

PMID:
8125450
24.

Comparison of Three Selective Enrichment Methods for the Isolation of Listeria monocytogenes from Naturally Contaminated Foods.

Hayes PS, Graves LM, Swaminathan B, Ajello GW, Malcolm GB, Weaver RE, Ransom R, Deaver K, Plikaytis BD, Schuchat A, Wenger JD, Pinner RW, Broome CV; LISTERIA STUDY GROUP.

J Food Prot. 1992 Dec;55(12):952-959. doi: 10.4315/0362-028X-55.12.952.

PMID:
31084098
25.

Risk factors for deaths in children under 5 years old in Bagamoyo district, Tanzania.

Mtango FD, Neuvians D, Broome CV, Hightower AW, Pio A.

Trop Med Parasitol. 1992 Dec;43(4):229-33.

PMID:
1293726
26.

Comparative efficacy of oral rifampin and topical chloramphenicol in eradicating conjunctival carriage of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group.

Perkins BA, Tondella ML, Bortolotto IM, Takano OA, da Silva GA, Irino K, Brandileone MC, Harrison LH, Wenger JD, Broome CV.

Pediatr Infect Dis J. 1992 Sep;11(9):717-21.

PMID:
1448311
27.

Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group.

Pinner RW, Onyango F, Perkins BA, Mirza NB, Ngacha DM, Reeves M, DeWitt W, Njeru E, Agata NN, Broome CV.

J Infect Dis. 1992 Aug;166(2):359-64.

PMID:
1634807
28.

Invasive Haemophilus influenzae disease: a population-based evaluation of the role of capsular polysaccharide serotype. Haemophilus Influenzae Study Group.

Wenger JD, Pierce R, Deaver K, Franklin R, Bosley G, Pigott N, Broome CV.

J Infect Dis. 1992 Jun;165 Suppl 1:S34-5. No abstract available.

PMID:
1588172
29.

Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group.

Pinner RW, Schuchat A, Swaminathan B, Hayes PS, Deaver KA, Weaver RE, Plikaytis BD, Reeves M, Broome CV, Wenger JD.

JAMA. 1992 Apr 15;267(15):2046-50.

PMID:
1552640
30.

Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group.

Schuchat A, Deaver KA, Wenger JD, Plikaytis BD, Mascola L, Pinner RW, Reingold AL, Broome CV.

JAMA. 1992 Apr 15;267(15):2041-5.

PMID:
1552639
31.

Detection of meningitis epidemics in Africa: a population-based analysis.

Moore PS, Plikaytis BD, Bolan GA, Oxtoby MJ, Yada A, Zoubga A, Reingold AL, Broome CV.

Int J Epidemiol. 1992 Feb;21(1):155-62.

PMID:
1544747
32.

Vaccine efficacy determination.

Broome CV.

NIPH Ann. 1991 Dec;14(2):219-21; discussion 222-4.

PMID:
1812435
33.

Pneumococcal vaccine--past, present, and future.

Broome CV, Breiman RF.

N Engl J Med. 1991 Nov 21;325(21):1506-8. No abstract available.

PMID:
1944428
34.

Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta.

Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, Broome CV.

JAMA. 1991 Aug 28;266(8):1112-4.

PMID:
1865545
35.
36.

Meningococcal disease in the United States--1986. Meningococcal Disease Study Group.

Pinner RW, Gellin BG, Bibb WF, Baker CN, Weaver R, Hunter SB, Waterman SH, Mocca LF, Frasch CE, Broome CV.

J Infect Dis. 1991 Aug;164(2):368-74.

PMID:
1906910
37.

Comparison of cold enrichment and U.S. Department of Agriculture methods for isolating Listeria monocytogenes from naturally contaminated foods. The Listeria Study Group.

Hayes PS, Graves LM, Ajello GW, Swaminathan B, Weaver RE, Wenger JD, Schuchat A, Broome CV.

Appl Environ Microbiol. 1991 Aug;57(8):2109-13.

38.

Listeria monocytogenes CAMP reaction.

Schuchat A, Swaminathan B, Broome CV.

Clin Microbiol Rev. 1991 Jul;4(3):396. No abstract available.

39.

Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population.

Schuchat A, Broome CV, Hightower A, Costa SJ, Parkin W.

JAMA. 1991 Jun 26;265(24):3275-9.

PMID:
2046109
40.

A cluster of meningococcal disease on a school bus following epidemic influenza.

Harrison LH, Armstrong CW, Jenkins SR, Harmon MW, Ajello GW, Miller GB Jr, Broome CV.

Arch Intern Med. 1991 May;151(5):1005-9.

PMID:
2025124
41.

Epidemiology of human listeriosis.

Schuchat A, Swaminathan B, Broome CV.

Clin Microbiol Rev. 1991 Apr;4(2):169-83. Review. Erratum in: Clin Microbiol Rev 1991 Jul;4(3):396.

42.

Outbreak of neonatal listeriosis associated with mineral oil.

Schuchat A, Lizano C, Broome CV, Swaminathan B, Kim C, Winn K.

Pediatr Infect Dis J. 1991 Mar;10(3):183-9.

PMID:
2041663
43.

The epidemiology of listeriosis in the United States--1986. Listeriosis Study Group.

Gellin BG, Broome CV, Bibb WF, Weaver RE, Gaventa S, Mascola L.

Am J Epidemiol. 1991 Feb 15;133(4):392-401.

PMID:
1899779
44.

Toxic shock syndrome and tampons.

Schuchat A, Broome CV.

Epidemiol Rev. 1991;13:99-112. Review.

PMID:
1662639
45.

Listeria monocytogenes Contamination of Turkey Franks: Evaluation of a Production Facility.

Wenger JD, Swaminathan B, Hayes PS, Green SS, Pratt M, Pinner RW, Schuchat A, Broome CV.

J Food Prot. 1990 Dec;53(12):1015-1019. doi: 10.4315/0362-028X-53.12.1015.

PMID:
31018263
46.

Day care characteristics associated with Haemophilus influenzae disease. Haemophilus influenzae Study Group.

Wenger JD, Harrison LH, Hightower A, Broome CV.

Am J Public Health. 1990 Dec;80(12):1455-8.

47.

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV.

J Infect Dis. 1990 Dec;162(6):1316-23.

PMID:
2230261
48.

Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis.

Moore PS, Hierholzer J, DeWitt W, Gouan K, Djoré D, Lippeveld T, Plikaytis B, Broome CV.

JAMA. 1990 Sep 12;264(10):1271-5.

PMID:
2117679
49.

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta.

Schuchat A, Oxtoby M, Cochi S, Sikes RK, Hightower A, Plikaytis B, Broome CV.

J Infect Dis. 1990 Sep;162(3):672-7.

PMID:
2201741
50.

Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion.

Johnson SE, Swaminathan B, Moore P, Broome CV, Parvin M.

J Infect Dis. 1990 Aug;162(2):557-9.

PMID:
2373880

Supplemental Content

Loading ...
Support Center